| Study |
Reference |
|
Bérard, 2018
|
Bérard A Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes. Ann Rheum Dis 2018;77:500-509
|
|
Chambers (Unexposed control, disease free), 2010
|
Chambers CD Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 2010;62:1494-503
|
|
Chambers (Unexposed control, sick), 2010
|
Chambers CD Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 2010;62:1494-503
|
|
Karadag, 2013
|
Karadag Pregnancy outcomes of rheumatic patients with pre/peri gestational leflunomide exposure Ann Rheum Dis 2013;72(Suppl 3): A896–7.
|
|
Langen, 2014
|
Langen High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol 2014; 31:9-14
|
|
Viktil (Controls exposed to other treatments), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
|
Viktil (Controls unexposed, NOS), 2012
|
Viktil Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41:196-201
|
